Cargando…
Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases
Recombinant adeno-associated virus (rAAV) vectors are gene therapy delivery tools that offer a promising platform for the treatment of neurodegenerative diseases. Keeping up with developments in this fast-moving area of research is a challenge. This review was thus written with the intention to intr...
Autores principales: | Li, Leyao, Vasan, Lakshmy, Kartono, Bryan, Clifford, Kevan, Attarpour, Ahmadreza, Sharma, Raghav, Mandrozos, Matthew, Kim, Ain, Zhao, Wenda, Belotserkovsky, Ari, Verkuyl, Claire, Schmitt-Ulms, Gerold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603849/ https://www.ncbi.nlm.nih.gov/pubmed/37893099 http://dx.doi.org/10.3390/biomedicines11102725 |
Ejemplares similares
-
The cellular prion protein interacts with and promotes the activity of Na,K-ATPases
por: Williams, Declan, et al.
Publicado: (2021) -
Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases
por: Qu, Yuan, et al.
Publicado: (2019) -
Battling Neurodegenerative Diseases with Adeno-Associated Virus-Based Approaches
por: Mijanović, Olja, et al.
Publicado: (2020) -
Vascular origins of low‐frequency oscillations in the cerebrospinal fluid signal in resting‐state fMRI: Interpretation using photoplethysmography
por: Attarpour, Ahmadreza, et al.
Publicado: (2021) -
An emerging role of the cellular prion protein as a modulator of a morphogenetic program underlying epithelial-to-mesenchymal transition
por: Mehrabian, Mohadeseh, et al.
Publicado: (2014)